Effects of α-Linolenic Acid and Arachidonic Acid on the Cytotoxicity and Steatosis of HepG2 Cells
5 affiliations
- 1Nanjing Tech University , , , ,
- 2Shenzhen Nanshan People’s Hospital, Affiliated Nanshan Hospital of Shenzhen University , , , ,
- 3Yiyang Medical College , , ,
- 4Fujian Medical University , , , ,
- 5Zhongshan Hospital of Xiamen University , , , ,
Abstract
Hepatic steatosis, characterized by excessive triglyceride (TG) accumulation in hepatocytes, serves as the initiating event in the early phase of metabolic dysfunction-associated fatty liver disease (MAFLD). Polyunsaturated fatty acids (PUFAs) exert differential modulatory effects on hepatic steatosis, but the underlying lipidomic remodeling remains incompletely understood. In this study, we systematically investigated the impacts of α-linolenic acid (ALA) and arachidonic acid (AA) on lipid accumulation, inflammation, and cytotoxicity in fattyacid-induced HepG2 cells. Our data indicated that ALA at concentrations >300 μM and AA at >150 μM significantly inhibited cell viability. In fatty acid-induced steatotic HepG2 cells, 100 μM ALA significantly reduced both triglyceride (TG) and total cholesterol (TC) levels, whereas 100 μM AA significantly increased TG levels without affecting TC content. Furthermore, quantitative real-time PCR revealed that 100 μM ALA significantly downregulated the transcriptional expression of NF-κB, TNF-α, and IL-6, while 100 μM AA upregulated the expression of these three factors. The untargeted metabolomic profiling and KEGG pathway enrichment analysis showed that ALA significantly modulated glycerophospholipid metabolism, amino acid metabolism, nucleotide metabolism, and central carbon metabolism in steatotic HepG2 cells. Lipidomics analysis further demonstrated that ALA, through conversion to DHA and EPA, remodeled TG molecular species and was incorporated into multiple membrane phospholipids. Furthermore, Drug Affinity Responsive Target Stability (DARTS) and molecular docking results indicated that choline kinase α (CHKA) might be a potential target of ALA in HepG2 cells. Conclusively, ALA might contribute to the progression of hepatocyte steatosis by remodeling TG molecular species, incorporating into membrane phospholipids, modulating glycerophospholipid metabolism, and targeting CHKA.
Related
- Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel 1,2,4-Triazole-Functionalized Benzene-Sulfonate Derivatives as Potential Enzyme Inhibitors and Cytotoxicity in HepG2 Cells.
- Elucidation of the antimelanogenic effects of linoleic acid- and α-linolenic acid-derived solutions on B16F10 melanoma cells
- Cytotoxic effects and modulation of BAX/BCL-2 gene expression induced by plant-derived cerium oxide nanoparticles in HepG2 cells
- Formulation, Characterization, and Preliminary In Vitro Evaluation of Letrozole Incorporated Eudragit® RS 100 Nanoparticles Using HepG2 Cells
- Combinatorial treatment with formononetin and magnolol induces synergistic cytotoxicity and suppresses migration in glioblastoma cells
BibTeX
@article{yin2026effects,
title = {{Effects of α-Linolenic Acid and Arachidonic Acid on the Cytotoxicity and Steatosis of HepG2 Cells}},
author = {Shiyu Yin and Yihuan Guo and Zhichao Xu and Qin Yan and Hongyan Wang and Fang Fang and Zhijian Yu and Shiqing Han and Chaoqin Zhang and Xianqiong Gong},
journal = {ACS Omega},
year = {2026},
month = oct,
doi = {10.1021/acsomega.5c11412},
url = {https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.5c11412/5454633/Effects-of-Linolenic-Acid-and-Arachidonic-Acid-on},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Effects of α-Linolenic Acid and Arachidonic Acid on the Cytotoxicity and Steatosis of HepG2 Cells
AU - Shiyu Yin
AU - Yihuan Guo
AU - Zhichao Xu
AU - Qin Yan
AU - Hongyan Wang
AU - Fang Fang
AU - Zhijian Yu
AU - Shiqing Han
AU - Chaoqin Zhang
AU - Xianqiong Gong
PY - 2026
DA - 2026/10/20
JO - ACS Omega
DO - 10.1021/acsomega.5c11412
UR - https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.5c11412/5454633/Effects-of-Linolenic-Acid-and-Arachidonic-Acid-on
AB - Hepatic steatosis, characterized by excessive triglyceride (TG) accumulation in hepatocytes, serves as the initiating event in the early phase of metabolic dysfunction-associated fatty liver disease (MAFLD). Polyunsaturated fatty acids (PUFAs) exert differential modulatory effects on hepatic steatosis, but the underlying lipidomic remodeling remains incompletely understood. In this study, we systematically investigated the impacts of α-linolenic acid (ALA) and arachidonic acid (AA) on lipid accumulation, inflammation, and cytotoxicity in fattyacid-induced HepG2 cells. Our data indicated that ALA at concentrations >300 μM and AA at >150 μM significantly inhibited cell viability. In fatty acid-induced steatotic HepG2 cells, 100 μM ALA significantly reduced both triglyceride (TG) and total cholesterol (TC) levels, whereas 100 μM AA significantly increased TG levels without affecting TC content. Furthermore, quantitative real-time PCR revealed that 100 μM ALA significantly downregulated the transcriptional expression of NF-κB, TNF-α, and IL-6, while 100 μM AA upregulated the expression of these three factors. The untargeted metabolomic profiling and KEGG pathway enrichment analysis showed that ALA significantly modulated glycerophospholipid metabolism, amino acid metabolism, nucleotide metabolism, and central carbon metabolism in steatotic HepG2 cells. Lipidomics analysis further demonstrated that ALA, through conversion to DHA and EPA, remodeled TG molecular species and was incorporated into multiple membrane phospholipids. Furthermore, Drug Affinity Responsive Target Stability (DARTS) and molecular docking results indicated that choline kinase α (CHKA) might be a potential target of ALA in HepG2 cells. Conclusively, ALA might contribute to the progression of hepatocyte steatosis by remodeling TG molecular species, incorporating into membrane phospholipids, modulating glycerophospholipid metabolism, and targeting CHKA.
SN - 2470-1343
ER -